AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $18,467,000 | +569.3% | 536,076 | +224.7% | 0.01% | +450.0% |
| Q2 2020 | $2,759,000 | +288.0% | 165,118 | +235.1% | 0.00% | +100.0% |
| Q1 2020 | $711,000 | -62.0% | 49,269 | -11.8% | 0.00% | 0.0% |
| Q4 2019 | $1,869,000 | +167.4% | 55,872 | +67.2% | 0.00% | 0.0% |
| Q3 2019 | $699,000 | +8.2% | 33,418 | +7.7% | 0.00% | 0.0% |
| Q2 2019 | $646,000 | -20.6% | 31,033 | -14.7% | 0.00% | 0.0% |
| Q1 2019 | $814,000 | +0.9% | 36,401 | +8.0% | 0.00% | 0.0% |
| Q4 2018 | $807,000 | -20.1% | 33,715 | -8.8% | 0.00% | 0.0% |
| Q3 2018 | $1,010,000 | -12.9% | 36,975 | -14.3% | 0.00% | 0.0% |
| Q2 2018 | $1,160,000 | -40.1% | 43,160 | -29.1% | 0.00% | -50.0% |
| Q1 2018 | $1,937,000 | +50.5% | 60,849 | +78.9% | 0.00% | +100.0% |
| Q4 2017 | $1,287,000 | +27.4% | 34,019 | -16.4% | 0.00% | 0.0% |
| Q3 2017 | $1,010,000 | +56.6% | 40,709 | +29.7% | 0.00% | 0.0% |
| Q2 2017 | $645,000 | -30.2% | 31,394 | -26.0% | 0.00% | 0.0% |
| Q1 2017 | $924,000 | +21.6% | 42,445 | +14.1% | 0.00% | 0.0% |
| Q4 2016 | $760,000 | +131.0% | 37,197 | +69.3% | 0.00% | – |
| Q3 2016 | $329,000 | +97.0% | 21,966 | +41.9% | 0.00% | – |
| Q2 2016 | $167,000 | -34.5% | 15,479 | -17.6% | 0.00% | – |
| Q1 2016 | $255,000 | -84.7% | 18,775 | -71.5% | 0.00% | -100.0% |
| Q3 2015 | $1,669,000 | – | 65,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|